Similarly, replacement therapy with tumor suppressor miR-34a can downregulate IL6 expression and suppress the pro-inflammatory effects associated with IL6/STAT3 activation, thereby aiding tumor suppression and invasion control in OC [176]. The gene discussed is STAT3; the disease is neoplasm.